In what extent anemia coexists with cognitive impairment in elderly: a cross-sectional study in Greece

Abstract

Background: A project aimed at studying the frequency of dementia and depression in the catchment area of the Health Centre of Chrissoupolis (HCCh), Northern Greece, was carried out. This paper reports the association between AD and anemia among the elderly participants in this Greek study.

Chronic Kidney Disease and Cognitive Impairment in the Elderly

“…For example, anemia is thought to be a key mediator of cognitive impairment in people with ESRD (22,23) and more recently has been associated with cognitive impairment in elderly individuals without known kidney disease (24). Inflammatory mechanisms have been implicated in the pathogenesis of vas- (25) and have been prospectively associated with cognitive decline (12).…”

Effects of Folate and Vitamin B12 on Cognitive Function in Adults and the Elderly

“…Among the studies that evaluated cognitive function, no significant correlation was found between vitamin B 12 serum levels and cognitive function test scores for any of the populations included. Among the studies that estimated odds ratios, only Argyriadou et al [23] found that the odds for low vitamin B 12 serum level are twofold higher in subjects with MMSE scores low enough to show cognitive impairment than in cognitively intact individuals (p = .03). The cutoff level for low vitamin B 12 in this paper was < 145 mg/mL.…”

“…Twenty-three studies examined the relationship between mean folate level and cognitive function or Parkinson's disease [12-14, 17-20, 22, 24-27, 29-33, 36, 39-43]; 9 examined the prevalence of folate deficiency [11,21,23,24,26,27,31,44,46]; and 11 assessed the risk of Alzheimer's disease, dementia, and cognitive impairment according to folate levels [10-12, 22, 23, 25, 29, 32, 41, 44]. The folate levels were assessed in the red blood cells, plasma, serum, cerebrospinal fluid, and blood.…”

Managing Alzheimer Dementia Tomorrow

“…41,42 The clock-drawing test is a simple measure of visuospatial ability; there is relatively little overlap between patients with Alzheimer disease and healthy control subjects early in the disease (Figure 3). 43 It is quick and easy to administer.…”